Skip to main content

Table 5 Assessment of diagnostic efficacy of the indexes alone

From: Application of attenuation coefficient in the assessment of hepatic involvement in children and adolescents with Wilson’s disease

Group

Parameter

AUC

95%CI

P*

Group 1 versus Group 2

ATT + SWM

0.718

0.562–0.843

0.480

ATT + APRI + FIB-4

0.863

0.726–0.948

0.038

ATT + SWM + APRI + FIB-4

0.863

0.726–0.948

0.038

Group 2 versus Group 3

ATT + SWM

0.696

0.523–0.836

0.393

ATT + APRI + FIB-4

0.743

0.573–0.872

0.643

ATT + SWM + APRI + FIB-4

0.737

0.566–0.867

0.724

Group 1 versus Group 3

ATT + SWM

0.871

0.734–0.954

0.507

ATT + APRI + FIB-4

0.909

0.781–0.975

0.231

ATT + SWM + APRI + FIB-4

0.911

0.784–0.976

0.215

  1. * the DeLong test